Partially purified bacteriocin kills malignant cells by apoptosis: programmed cell death
H Farkas-Himsley1, Y S Zhang, M Yuan
1Departement of Microbiology, Faculty of Medicine, University of Toronto, Ontario, Canada.
Cellular and Molecular Biology (Noisy-Le-Grand, France)
|August 1, 1992
Summary
Partially purified bacteriocins (PPB) selectively kill malignant cells by triggering DNA fragmentation through cell membrane receptors. This programmed cell death requires active cellular metabolism and involves endogenous endonucleases.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Bacterial proteins, specifically partially purified bacteriocins (PPB), have shown potential in selectively targeting malignant cells.
- Understanding the precise mechanism of PPB-induced cell death is crucial for therapeutic development.
Purpose of the Study:
- To investigate the mechanism by which partially purified bacteriocins (PPB) induce selective cell death in malignant cells.
- To elucidate the role of cellular metabolism and endogenous enzymes in PPB-mediated apoptosis.
Main Methods:
- Investigated DNA fragmentation kinetics following PPB-cell interaction.
- Assessed the requirement for ongoing cellular metabolism using inhibitors like actinomycin D and cycloheximide.
- Determined the role of PPB in triggering endogenous cellular endonucleases via cell membrane receptors.
Main Results:
- PPB-cell interaction initiated DNA fragmentation within one hour, peaking at six hours.
- The process was dependent on active cellular metabolism and inhibited by actinomycin D and cycloheximide.
- DNA fragmentation was triggered by PPB-cell membrane-receptor interaction, activating endogenous endonucleases, not direct DNA interaction.
Conclusions:
- PPB-induced cell death in malignant cells is a programmed, step-wise process involving apoptosis.
- The mechanism involves PPB signaling through cell surface receptors to activate endogenous cellular endonucleases.
- PPB does not need to penetrate the cell or act as a nuclease itself to induce cell death.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:30Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:22Cellular Injury V: Apoptosis and Autophagy
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...